NEO
NeoGenomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$17.38
−0.46%Leverage
- Debt / equity
- 0.57x
- Net debt / equity
- 0.39x
- Debt / assets
- 0.33x
- Debt / EBITDA
- 34.79x
- Net debt / EBITDA
- 23.50x
Liquidity & coverage
- Current ratio
- 3.60x
- Quick ratio
- 3.35x
- Cash ratio
- 1.37x
- Interest coverage
- -25.64x
- EBITDA / interest
- 4.99x
- Working capital
- $275.6M
Cash & dividend
- FCF / debt
- -0.02x
- Cash flow / debt
- 0.05x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026